Form 4 holding
Chief Financial Officer
Edesa Biotech, Inc.
- Security class
- Common Shares
- Shares / value
- 10,715
- Estimated value
- $28,230
- Report date
- 02 Nov 2022
- Price
- $2.63
- Ownership
- By Trust
Kathi Niffenegger
Insider Reports History
- Reporting-owner location
- Port Hueneme, CA
- Latest reporting-owner signature
-
/s/ Kathi Niffenegger
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Kathi Niffenegger
Form 4 holding
Chief Financial Officer
Edesa Biotech, Inc.
- Security class
- Common Share Warrants (Right to Buy)
- Shares / value
- 4,444
- Estimated value
- Report date
- 02 Nov 2022
- Price
- Ownership
- By Trust
- Underlying class
- Common Shares
- Underlying amount
Insider Reports Filed by Kathi Niffenegger
4
EDSA
Edesa Biotech, Inc.
- Report period
- 02 Nov 2022
- Transactions
- 3
- Transaction value
- +$9,999
- Accepted by SEC
- 04 Nov 2022, 15:27
- Role
- Chief Financial Officer
- Next action
- Open filing details
4
EDSA
Edesa Biotech, Inc.
- Report period
- 28 Feb 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 07 Mar 2022, 18:40
- Role
- Chief Financial Officer
- Next action
- Open filing details